Acrodermatitis Continua of Hallopeau Treated Successfully with Ustekinumab and Acitretin after Failure of Tumour Necrosis Factor Blockade and Anakinra

Publisher： Karger

E-ISSN： 1421-9832|230|2|97-100

ISSN： 1018-8665

Source： Dermatology, Vol.230, Iss.2, 2014-11, pp. : 97-100

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Acrodermatitis Continua of Hallopeau Is a Clinical Phenotype of DITRA: Evidence that It Is a Variant of Pustular Psoriasis

By  

Dermatology, Vol. 226, Iss. 1, 2013-02 ,pp. : 28-31

Karger

Access to resources Recommend Favorite

Successful Treatment of Acrodermatitis Continua of Hallopeau with Sequential Combination of Calcipotriol and Tacrolimus Ointments

By  

Dermatology, Vol. 211, Iss. 4, 2005-12 ,pp. : 351-355

Karger

Access to resources Recommend Favorite

Treatment of Acrodermatitis Continua of Hallopeau with TNF-Blocking Agents: Case Report and Review

By  

Dermatology, Vol. 220, Iss. 2, 2010-01 ,pp. : 154-158

Karger

Access to resources Recommend Favorite

Long-Term Control with Etanercept (Enbrel®) of a Severe Acrodermatitis Continua of Hallopeau Refractory to Infliximab (Remicade®)

By  

Dermatology, Vol. 217, Iss. 2, 2008-05 ,pp. : 137-139

Karger

Access to resources Recommend Favorite

Efficacy of Efalizumab in Psoriasis Patients Previously Treated with Tumour Necrosis Factor Blockers

By  

Dermatology, Vol. 219, Iss. 1, 2009-04 ,pp. : 48-53

Karger

Access to resources Recommend Favorite